FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and A...(R. Alpha-2 adrenergic receptoragonists f...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and Adolescents
Date:7/28/2009
R. Alpha-2 adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data.
J of Child and Adolesc Psychopharmacology. 2007;17:4:393-406.
5. MacDonald E, Kobilka BK, Scheinin M. Gene targeting-homing in on alpha-2-adrenoceptor subtype function. Trends in Pharmacol Sci. 1997;18:211-219.
6. Wang M, Arnsten AF, Brennan A, et al. ÿ±2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell. 2007;129:397-410.
7. Arnsten AF, Li BM. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry. 2005; 57:1377-1385.
8. Steere JC, Arnsten AFT. The alpha-2A noradrenergic agonist, guanfacine, improves visual object discrimination reversal performance in rhesus monkeys. Behav Neurosci. 1997;111:1-9.
9. Mao Z-M, Arnsten AFT, Li B-M. Local infusion of alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys. Biol Psychiatry. 1999;46:1259-1265.
10. Jakala P, Riekkinen M, Sirvio, J, et al. Guanfacine, but not clonidine, improves planning and working memory performance in humans. Neuropsychopharmacology. 1999;2[5]:460-470.
11. INTUNIV Data on File SPD503005; Shire plc. ISS Summary of Clinical Safety 2006; -: 1-190.
12. Pliszka S and the AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894-921.
13. Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psych. 2007; 164:942-948.
14. Mental health in the United States: Prevalence of diagnosis and
medication treat
'/>"/>
| SOURCE Shire Plc Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
2. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
3. European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
4. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
5. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
6. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
8. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
9. European Unions CHMP Issues Positive Opinion on Sugammadex
10. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
11. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
Post Your Comments:
(Date:11/27/2009)...heroptiontopreventillnessescausedbysubtypesAandBin...swire-USNewswire/--TheU.S.FoodandDrugAdministratio...opreventdiseasecausedbyinfluenzavirussubtypesAandB.../20090824/FDALOGO ) ,, Agriflu,manufacturedbyNo...vedusingtheFDA,sacceleratedapprovalpathway,whichhe...
(Date:11/27/2009)...KECITY,Nov.27/PRNewswire-FirstCall/--Booth-3646/So...emiersupplierofX-raytubesandflatpaneldigitalimaged...NAAnnualMeetinginChicago,Ill.fromNovember29-Decemb...logyformultiplemodalitiesaswellasspecializedcancer...owcasethelatestX-raytechnologyincluding: ,, Ab...
(Date:11/27/2009)...NGTON,Minn,Nov.27/PRNewswire/--ACUOTECHNOLOGIES,de...ftware,datamigrationtoolsandservices,ispleasedtoan...asapprovedapatentapplicationforan"AssetCommunicati...pleasedtoaddtheU.S.patenttoitsportfolioofintellect...roadlyprotectsAcuo,stechnologyanduseofassetmetainf...
Breaking Medicine Technology:FDA Approves Agriflu Seasonal Influenza Vaccine 2Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Nanosystems institute at UCLA Photron to collaborate on specialized instrumentation 14534 1Health Education Solutions 26apos 3B Advanced Cardiac Life Support Courses Gain Approval from American Academy of Physician Assistants 59779 1Health Education Solutions 26apos 3B Advanced Cardiac Life Support Courses Gain Approval from American Academy of Physician Assistants 59779 2Sunrise Enters into 13th Amendment to Credit Agreement Extending Maturity Date to December 2 2010 59775 1Sunrise Enters into 13th Amendment to Credit Agreement Extending Maturity Date to December 2 2010 59775 2Sunrise Enters into 13th Amendment to Credit Agreement Extending Maturity Date to December 2 2010 59775 3Sunrise Enters into 13th Amendment to Credit Agreement Extending Maturity Date to December 2 2010 59775 4[0] FDA Approves Agriflu Seasonal Influenza Vaccine[0] Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago[0] Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network
...Newswire/ -- Sinovac Biotech Ltd. (Amex:,SVA), a l...ced the,initiation of volunteer enrollment in its ...luenza vaccine. The preliminary results from this ... The randomized and double-blind trial is expecte...2 to 17, who will receive doses of 10ug,15ug or 30...
... Catalyst,Pharmaceutical Partners, Inc. (Nasdaq: ... or in-licenses, develops and commercializes presc...and obsessive compulsive,disorders, today announce...double-blind, placebo-controlled U.S. Phase II cli...f patients addicted to methamphetamine. CPP-109,an...
Other Medicine Technology:Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N1) Vaccine 2Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N1) Vaccine 3Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction 2Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction 3Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction 4(Date:11/27/2009)...s.,Nov.27/PRNewswire-FirstCall/--GSIGroupInc.(Pink...chnologyproductsandsemiconductorsystems,todayannou...asbeenscheduledforFriday,April30,2010.Thetimeandlo...viouslyannounced,theCompanyreceivedarequisitionnot...ntoftheCompany,soutstandingshares,pursuanttoSectio...
(Date:11/27/2009)...Nov.27/PRNewswire/-UploadableUSBpedometersmaybenew...nationofadvancedaccelerometerfunctionalityandautom...uracyofself-reporteddata.It,snowpossibletoaccurate...gram. ,, CoreHealthTechnologiesisoneofthefirstw...thchallengesareeasytoadministerandparticipatein......
(Date:11/27/2009)... Biotech firm Replikins Ltd. today issued it...nomic data. It shows that the lethality of the vi...ring the virus,s current outbreak in the spring of...2.0 (s.d. 0.1). The H1N1 infectivity count, howeve...oston (PRWEB) November 27, 2009 -- Biotech firm Re...
(Date:11/27/2009)...27/PRNewswire-USNewswire/--Consideredahighlyriskya...dorgantransplantationisnowalife-savingmainstreamop...redattheWinspearOperaHouseinDallasonNov.11.Leaders...bratethe25thanniversaryofBaylorRegionalTransplantI...antintheUnitedStates. ,, Itwas25yearsagothatBay...
(Date:11/27/2009)...O,Nov.27/PRNewswire-FirstCall/--TheGymboreeCorpora...OO,willpresentattheNASDAQOMX23rdInvestorProgram,wh...ednesday,December2,2009,at11:45a.m.GMT. ,, Toli...entationovertheInternet,pleaselogontowww.gymboree....nvestorandMediaRelations"andthen"ConferenceCalls&a...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3[0] GSI Group Calls Shareholders Meeting[0] New USB technology adds accountability and convenience to wellness programs[0] Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased[0] Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary[0] The Gymboree Corporation to Present at NASDAQ OMX 23rd Investor Program
..., Oct. 24 How many starving children,could you sa...://www.newscom.com/cgi-bin/prnh/20071024/NYW141 )...CEO of Diet Power, Inc.,His company has launched a...eight loss diet. Tell this new online computer th...
... 24 The ASPCA(R) (The American Society,for the Pr...nding to the,San Diego Humane Society for hay and ...k of devastating wildfires in California. (Logo: ...tragedy," said ASPCA President and CEO Ed Sayres.,...
...ould welcome a vaccine against the human papilloma...Quebec, Canada survey suggests. Research published...th shows that 91% of young women (18-25 year-olds)...Laval University hospital center in Quebec analyse...
... 24 It,s no shock that our insurance,premiums are...ose with,fixed incomes, the costs are particularly... Sloane explains. Listen to this report from AARP... and,photos for free and unrestricted use at http...
...Oct. 24 Kathleen M. Foley, MD,of Memorial Sloan-K... Fine,MD, of the University of Utah School of Medi...ucation and Leadership Award for 2007 at the 9th,A...ymptom management. The award and professional conf...
...r is often physicians, best strategy, experts say ... Serious medical errors don,t just affect the heal...tient,s relationship with his or her doctor, too, ...h -- or avoidance of -- the affected patient, say...
Other Medicine News:Health News:Lose Weight, Conquer World Hunger with www.DonateYourCalories.com 2Health News:ASPCA Provides Funding for Hay, Equine Expenses Following Outbreak of California Wildfires 2Health News:Two Physicians Recognized for Work in Pain and Symptom Management 2Health News:Doctor-Patient Bond Frays After Medical Mistake 2Health News:Doctor-Patient Bond Frays After Medical Mistake 3Health News:Doctor-Patient Bond Frays After Medical Mistake 4Lose Weight, Conquer World Hunger with www.DonateYourCalories.comASPCA Provides Funding for Hay, Equine Expenses Following Outbreak of California WildfiresCanadians welcome HPV vaccine -- but not at any priceAUDIO from Medialink and AARP: Cost of Living Adjustment Can't Keep UpTwo Physicians Recognized for Work in Pain and Symptom ManagementDoctor-Patient Bond Frays After Medical Mistake
Face & Chin Compression - Easy pull-on, upto neck
Chin Neck Bandage
Universal Facial Garment
Facial Mask
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |